170 related articles for article (PubMed ID: 20844987)
1. Frequency variations in the methylated pattern of p73/p21 genes and chromosomal aberrations correlating with different grades of glioma among south Indian population.
Palani M; Devan S; Arunkumar R; Vanisree AJ
Med Oncol; 2011 Dec; 28 Suppl 1():S445-52. PubMed ID: 20844987
[TBL] [Abstract][Full Text] [Related]
2. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma.
Yu J; Zhang H; Gu J; Lin S; Li J; Lu W; Wang Y; Zhu J
BMC Cancer; 2004 Sep; 4():65. PubMed ID: 15367334
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population.
Jha AK; Nikbakht M; Jain V; Sehgal A; Capalash N; Kaur J
Mol Biol Rep; 2012 Sep; 39(9):9145-57. PubMed ID: 22729911
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the p73 gene in gliomas.
Watanabe T; Huang H; Nakamura M; Wischhusen J; Weller M; Kleihues P; Ohgaki H
Acta Neuropathol; 2002 Oct; 104(4):357-62. PubMed ID: 12200621
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis.
Zhao Y; Guo J; Zhang X; Zhang Z; Gu S; Fei C; Li X; Chang C
Am J Clin Pathol; 2013 Dec; 140(6):819-27. PubMed ID: 24225749
[TBL] [Abstract][Full Text] [Related]
6. Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel.
Shen L; Kondo Y; Ahmed S; Boumber Y; Konishi K; Guo Y; Chen X; Vilaythong JN; Issa JP
Cancer Res; 2007 Dec; 67(23):11335-43. PubMed ID: 18056460
[TBL] [Abstract][Full Text] [Related]
7. Methylation and expression patterns of tropomyosin-related kinase genes in different grades of glioma.
Palani M; Arunkumar R; Vanisree AJ
Neuromolecular Med; 2014 Sep; 16(3):529-39. PubMed ID: 24840578
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation profiles associated with glioma subtypes and EZH2 and IGFBP2 mRNA expression.
Zheng S; Houseman EA; Morrison Z; Wrensch MR; Patoka JS; Ramos C; Haas-Kogan DA; McBride S; Marsit CJ; Christensen BC; Nelson HH; Stokoe D; Wiemels JL; Chang SM; Prados MD; Tihan T; Vandenberg SR; Kelsey KT; Berger MS; Wiencke JK
Neuro Oncol; 2011 Mar; 13(3):280-9. PubMed ID: 21339190
[TBL] [Abstract][Full Text] [Related]
9. The expression of p73, p21 and MDM2 proteins in gliomas.
Kamiya M; Nakazato Y
J Neurooncol; 2002 Sep; 59(2):143-9. PubMed ID: 12241107
[TBL] [Abstract][Full Text] [Related]
10. Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders.
Kawamata N; Inagaki N; Mizumura S; Sugimoto KJ; Sakajiri S; Ohyanagi-Hara M; Oshimi K
Eur J Haematol; 2005 May; 74(5):424-9. PubMed ID: 15813917
[TBL] [Abstract][Full Text] [Related]
11. Identification of MGMT promoter methylation sites correlating with gene expression and IDH1 mutation in gliomas.
Zhang J; Yang JH; Quan J; Kang X; Wang HJ; Dai PG
Tumour Biol; 2016 Oct; 37(10):13571-13579. PubMed ID: 27468718
[TBL] [Abstract][Full Text] [Related]
12. Methylated tumor-specific DNA as a plasma biomarker in patients with glioma.
Weaver KD; Grossman SA; Herman JG
Cancer Invest; 2006 Feb; 24(1):35-40. PubMed ID: 16466990
[TBL] [Abstract][Full Text] [Related]
13. Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.
Harr MW; Graves TG; Crawford EL; Warner KA; Reed CA; Willey JC
Mol Cancer; 2005 Jul; 4():23. PubMed ID: 16014176
[TBL] [Abstract][Full Text] [Related]
14. Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors.
Kuo LT; Kuo KT; Lee MJ; Wei CC; Scaravilli F; Tsai JC; Tseng HM; Kuo MF; Tu YK
Int J Cancer; 2009 Jun; 124(12):2872-9. PubMed ID: 19330828
[TBL] [Abstract][Full Text] [Related]
15. Methylation Status of the RIZ1 Gene Promoter in Human Glioma Tissues and Cell Lines.
Zhang C; Meng W; Wang J; Lu Y; Hu G; Hu L; Ma J
Cell Mol Neurobiol; 2017 Aug; 37(6):1021-1027. PubMed ID: 27757741
[TBL] [Abstract][Full Text] [Related]
16. Aberrant promoter hypermethylation profile of cell cycle regulatory genes in malignant astrocytomas.
Ohta T; Watanabe T; Katayama Y; Yoshino A; Yachi K; Ogino A; Komine C; Fukushima T
Oncol Rep; 2006 Nov; 16(5):957-63. PubMed ID: 17016577
[TBL] [Abstract][Full Text] [Related]
17. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors].
Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y
Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
[TBL] [Abstract][Full Text] [Related]
19. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms.
Gomes CC; Diniz MG; Oliveira CS; Tavassoli M; Odell EW; Gomez RS; De Marco L
Oral Dis; 2011 Sep; 17(6):564-71. PubMed ID: 21332605
[TBL] [Abstract][Full Text] [Related]
20. Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma.
Wiestler B; Capper D; Sill M; Jones DT; Hovestadt V; Sturm D; Koelsche C; Bertoni A; Schweizer L; Korshunov A; Weiß EK; Schliesser MG; Radbruch A; Herold-Mende C; Roth P; Unterberg A; Hartmann C; Pietsch T; Reifenberger G; Lichter P; Radlwimmer B; Platten M; Pfister SM; von Deimling A; Weller M; Wick W
Acta Neuropathol; 2014 Oct; 128(4):561-71. PubMed ID: 25008768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
